PubRank

M J Zigmond

Author PubWeight™ 131.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999 32.32
2 Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 1989 2.75
3 Promoting responsible conduct in research through "survival skills" workshops: some mentoring is best done in a crowd. Sci Eng Ethics 2001 2.01
4 Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci U S A 1996 1.75
5 Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci 2001 1.66
6 Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience 1988 1.54
7 Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience 1995 1.37
8 Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res 1990 1.20
9 Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats. J Pharmacol Exp Ther 1977 1.15
10 The effects of stress on central dopaminergic neurons: possible clinical implications. Neurochem Res 1997 1.09
11 Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J Neurochem 1995 1.09
12 Amphetamine and operant behavior in rats: relationship between drug effect and control response rate. J Comp Physiol Psychol 1974 1.08
13 Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience 2001 1.07
14 Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat. J Neurochem 1994 1.07
15 The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart. Br J Pharmacol 1983 1.06
16 Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch Neurol 1984 1.06
17 Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic acid and glutathione. J Neurochem 1994 1.05
18 Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J Neurochem 1996 1.04
19 Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease. Adv Exp Med Biol 1996 1.02
20 Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 1995 1.02
21 Maternal separation alters nerve growth factor and corticosterone levels but not the DNA methylation status of the exon 1(7) glucocorticoid receptor promoter region. Metab Brain Dis 2009 0.99
22 Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience 1997 0.98
23 Increased transcription of the tyrosine hydroxylase gene in individual locus coeruleus neurons following footshock stress. Neuroscience 2000 0.97
24 Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res 1984 0.94
25 Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences. Neuroscience 1997 0.94
26 Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions. Neuroscience 1990 0.92
27 Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats. Science 1972 0.92
28 Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor. J Neurosci 1991 0.92
29 In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids. J Neural Transm Gen Sect 1993 0.92
30 Parkinson's disease: studies with an animal model. Life Sci 1984 0.89
31 Impact of corticotropin-releasing hormone on extracellular norepinephrine in prefrontal cortex after chronic cold stress. J Neurochem 1997 0.89
32 Stress-induced neurological impairments in an animal model of parkinsonism. Ann Neurol 1985 0.89
33 Paradoxical kinesia in parkinsonism is not caused by dopamine release. Studies in an animal model. Arch Neurol 1989 0.89
34 Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis. J Neurosci 1989 0.89
35 Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. Science 1973 0.88
36 Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time. Neuropsychopharmacology 2002 0.87
37 Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids. J Neurochem 1993 0.87
38 Effect of chronic cold exposure on tyrosine hydroxylase mRNA in rat adrenal gland. Brain Res 1985 0.87
39 Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage. J Neurosci 1987 0.87
40 Effects of cold exposure on rat adrenal tyrosine hydroxylase: an analysis of RNA, protein, enzyme activity, and cofactor levels. J Neurochem 1990 0.87
41 Loss of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites. J Neural Transm Suppl 1997 0.86
42 Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. J Pharmacol Exp Ther 1990 0.86
43 Inhibitory glutamatergic regulation of evoked dopamine release in striatum. Neuroscience 2000 0.86
44 Intrahypothalamic injections of kainic acid produce feeding and drinking deficits in rats. Brain Res 1978 0.85
45 Tyrosine hydroxylase activity and catecholamine biosynthesis in the adrenal medulla of rats during stress. J Pharmacol Exp Ther 1985 0.85
46 Recovery of hippocampal dentate granule cell responsiveness to entorhinal cortical input following norepinephrine depletion. Brain Res 1993 0.85
47 Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion. Brain Res 1989 0.85
48 Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats. Exp Neurol 2005 0.85
49 High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment. J Neurochem 1984 0.84
50 Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis. Brain Res 1986 0.84
51 The effect of altered dopaminergic activity on food intake in the rat: evidence for an optimal level of dopaminergic activity for behavior. Prog Neuropsychopharmacol 1980 0.84
52 High glutamate concentrations evoke Ca(++)-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. J Pharmacol Exp Ther 1991 0.84
53 Characterization of [3H]GABA release from striatal slices: evidence for a calcium-independent process via the GABA uptake system. Neuroscience 1988 0.84
54 Environmental stress increases extracellular dopamine in striatum of 6-hydroxydopamine-treated rats: in vivo microdialysis studies. Brain Res 1990 0.84
55 Maternal separation exaggerates the toxic effects of 6-hydroxydopamine in rats: implications for neurodegenerative disorders. Stress 2008 0.83
56 Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm. Psychopharmacology (Berl) 2000 0.83
57 Incubation of tissue slices in the absence of Ca2+ and Mg2+ can cause nonspecific damage. J Neurochem 1991 0.83
58 Hepatic tyrosine transaminase rhythm: interaction of environmental lighting, food consumption and dietary protein content. J Nutr 1969 0.83
59 Muscarinic receptor subclasses: evidence from binding studies. Adv Biochem Psychopharmacol 1983 0.82
60 Brain catecholamines and the central control of food intake. Int J Obes 1984 0.82
61 Analysis of tyrosine hydroxylase gene transcription using an intron specific probe. J Neurosci Methods 2000 0.82
62 The effects of L-dopa on in vitro dopamine release from striatum. Brain Res 1990 0.82
63 Sensitization of norepinephrine release in medial prefrontal cortex: effect of different chronic stress protocols. Brain Res 1999 0.82
64 Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine. Biochem Pharmacol 1986 0.81
65 Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine. Eur J Pharmacol 1989 0.81
66 Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism. Arch Neurol 1991 0.81
67 Daily rhythm in the accumulation of brain catechol-amines synthesized fom circulating H3-tyrosine. J Pharmacol Exp Ther 1970 0.81
68 The effect of L-dopa on in vivo dopamine release from nigrostriatal bundle neurons. Brain Res 1988 0.81
69 Short- and long-term changes in adrenal tyrosine hydroxylase activity during insulin-induced hypoglycemia and cold stress. Brain Res 1983 0.81
70 Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum. Brain Res Bull 1998 0.81
71 Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine. J Pharmacol Exp Ther 1993 0.80
72 Molecular adaptations in catecholamine biosynthesis induced by cold stress and sympathectomy. J Neurosci Res 1986 0.80
73 Subtotal destruction of central noradrenergic projections increases the firing rate of locus coeruleus cells. Brain Res 1983 0.80
74 Compensatory increase in tyrosine hydroxylase activity in rat brain after intraventricular injections of 6-hydroxydopamine. Science 1980 0.80
75 A radioenzymatic assay for catecholamines and dihydroxyphenylacetic acid. Life Sci 1978 0.80
76 Do the right thing. Curr Biol 1999 0.80
77 Supersensitivity after intraventricular 6-hydroxydopamine: relation to dopamine depletion. Experientia 1980 0.80
78 High affinity choline uptake in striatum and hippocampus: differential effects of treatments which release acetylcholine. Life Sci 1978 0.80
79 Effect of haloperidol on dopamine synthesis and tyrosine hydroxylase in striatal synaptosomes. J Pharmacol Exp Ther 1979 0.80
80 Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience 1992 0.79
81 Short and long term changes in tyrosine hydroxylase activity in rat brain after subtotal destruction of central noradrenergic neurons. J Neurosci 1981 0.79
82 Effects of NADH on dopamine release in rat striatum. Synapse 2000 0.79
83 Caffeine restores feeding response to 2-deoxy-D-glucose in 6-hydroxydopamine-treated rats. Nature 1977 0.79
84 Sprouting of serotoninergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study. J Comp Neurol 1986 0.79
85 Olfactory bulb removal: effects on brain norepinephrine. Proc Natl Acad Sci U S A 1969 0.79
86 Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats. J Comp Physiol Psychol 1974 0.79
87 Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum. Eur J Pharmacol 1985 0.79
88 Tyrosine hydroxylase content of residual striatal dopamine nerve terminals following 6-hydroxydopamine administration: a flow cytometric study. J Neurochem 1989 0.78
89 Effect of dopamine-depleting brain lesions in rat pups: role of striatal serotonergic neurons in behavior. Behav Neurosci 1987 0.78
90 Ingestive behavior following damage to central dopamine neurons: implications for homeostasis and recovery of function. Adv Biochem Psychopharmacol 1974 0.78
91 Environmental stimuli but not homeostatic challenges produce apparent increases in dopaminergic activity in the striatum: an analysis by in vivo voltammetry. Brain Res 1983 0.77
92 Studies on the interaction between catecholamines and tyrosine aminotransferase in brain. Biochem Pharmacol 1973 0.77
93 Rats given dopamine-depleting brain lesions as neonates do not respond to acute homeostatic imbalances as adults. Behav Neurosci 1986 0.77
94 Long-term effects of dopamine-depleting brain lesions on spontaneous activity of type II striatal neurons: relation to behavioral recovery. Brain Res 1986 0.77
95 Acute homeostatic imbalances reinstate sensorimotor dysfunctions in rats with lateral hypothalamic lesions. J Comp Physiol Psychol 1979 0.77
96 Neural control of adenylate cyclase responsiveness in brown adipose tissue. J Pharmacol Exp Ther 1985 0.77
97 Dopamine may influence striatal GABA release via three separate mechanisms. Brain Res 1989 0.77
98 Selective presynaptic cholinergic neurotoxicity following intrahippocampal AF64A injection in rats. J Neurochem 1983 0.77
99 Glucoregulatory feeding by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. Science 1975 0.77
100 Resistance to central norepinephrine depletion and decreased mortality in rats chronically exposed to electric foot shock. J Neurovisc Relat 1970 0.76
101 Rats given dopamine-depleting brain lesions as neonates are subsensitive to dopaminergic antagonists as adults. Behav Neurosci 1985 0.76
102 In vivo stimulation of D1 receptors increases the phosphorylation of proteins in the striatum. J Neurochem 1990 0.76
103 Calcium-independent GABA release from striatal slices: the role of calcium channels. Neuroscience 1990 0.76
104 Stress-induced increase in extracellular dopamine in striatum: role of glutamatergic action via N-methyl-D-aspartate receptors in substantia nigra. Brain Res 2001 0.76
105 The behavioral effects of D-amphetamine are correlated with its effects on cAMP in different brain regions. Brain Res 1979 0.76
106 A cholinergic antagonist blocks cold stress-induced alterations in rat adrenal tyrosine hydroxylase mRNA. Brain Res 1988 0.76
107 The effects of phosphorylating conditions on tyrosine hydroxylase activity are influenced by assay conditions and brain region. Life Sci 1981 0.76
108 Pharmacologic tools in autonomic nervous system research. Anesthesiology 1968 0.76
109 Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats. Brain Res 1985 0.76
110 Regulation of dopamine synthesis in striatal synaptosomes during depolarization. Brain Res 1979 0.76
111 Disruption of copulation in male rats after hypothalamic lesions: a behavioral, anatomical and neurochemical analysis. Brain Res 1973 0.76
112 Inhibition of striatal acetylcholine release by serotonin and dopamine after the intracerebral administration of 6-hydroxydopamine to neonatal rats. Brain Res 1988 0.76
113 Short-term effects of dopamine-depleting brain lesions on spontaneous activity of striatal neurons: relation to local dopamine concentration and behavior. Brain Res 1986 0.75
114 Dopamine released from mesencephalic transplants restores modulation of striatal acetylcholine release after neonatal 6-hydroxydopamine: an in vitro analysis. Exp Neurol 1989 0.75
115 Na+ influx through Ca2+ channels can promote striatal GABA efflux in Ca(2+)-deficient conditions in response to electrical field depolarization. Brain Res 1993 0.75
116 Effects of Purkinje cell degeneration on the noradrenergic projection to mouse cerebellar cortex. Brain Res 1984 0.75
117 Influence of calcium on dopamine synthesis and tyrosine hydroxylase activity in rat striatum. J Neurochem 1982 0.75
118 Inhibition of striatal acetylcholine release by endogenous serotonin. Brain Res 1988 0.75
119 Proceedings: The effects on ingestive behaviors of damage to central dopamine-containing neurons. Psychopharmacol Bull 1974 0.75
120 Lesions of the dopaminergic nigrostriatal system in neonatal rats: effects on the electrophysiological activity of striatal neurons recorded during adulthood. Brain Res 1990 0.75
121 Dopaminergic inhibition of striatal GABA release after 6-hydroxydopamine. Brain Res 1996 0.75
122 Increased neostriatal tyrosine hydroxylation during stress: role of extracellular dopamine and excitatory amino acids. J Neurochem 1996 0.75
123 Fluphenazine-induced decline in striatal acetylcholine content is not abolished by exogenous choline. Neuropharmacology 1981 0.75
124 Trigeminal lemniscal lesions and the lateral hypothalamic syndrome. Science 1975 0.75
125 Advances in Neurochemistry: Monitoring Neurotransmitter Release during Behavior. Science 1987 0.75
126 Isolation of a rat adrenal cDNA clone encoding phenylethanolamine N-methyltransferase and cold-induced alterations in adrenal PNMT mRNA and protein. Brain Res Mol Brain Res 1989 0.75
127 Effects of dopamine depletion on the spontaneous activity of type I striatal neurons: relation to local dopamine concentration and motor behavior. Synapse 1987 0.75
128 Effect of lateral hypothalamic lesions on uptake of norepinephrine by brain homogenates. J Pharmacol Exp Ther 1971 0.75
129 The effect of neuroleptics on acetylcholine concentration and choline uptake in striatum: Implications for regulation of acetylcholine metabolism. J Pharmacol Exp Ther 1978 0.75
130 Out of Africa: first international meeting. Trends Neurosci 1993 0.75
131 Ineffectiveness of sexually arousing stimulation after hypothalamic lesions in the rat. Physiol Behav 1974 0.75
132 Spontaneous activity of type II but not type I striatal neurons is correlated with recovery of behavioral function after dopamine-depleting brain lesions. Brain Res 1988 0.75
133 Recovery of chronotropic responsiveness after systemic 6-hydroxydopamine treatment: studies in the pithed rat. J Pharmacol Exp Ther 1987 0.75
134 Partial damage to the noradrenergic bundle increases tyrosine hydroxylase activity in noradrenergic terminals of hippocampus but not cerebellum. Brain Res 1984 0.75
135 Release of endogenous GABA can occur through Ca(2+)-dependent and Ca(2+)-independent processes. Neurochem Int 1989 0.75
136 Tyrosine hydroxylase activity in the sympathoadrenal system under basal and stressful conditions: effect of 6-hydroxydopamine. J Pharmacol Exp Ther 1985 0.75